[Time interval between ovarian cancer surgery and chemotherapy--secondary publication?].
Worldwide, much effort goes into performing optimal surgery in treatment of epithelial ovarian cancer (EOC). However, the optimal timing (TI) of postoperative chemotherapy for ovarian cancer remains poorly defined. The relevant literature comprises seven studies with varying characteristics and includes different prognostic factors. The general supposition is that the time interval does not have a prognostic influence, but experimental studies have shown that it does affect cancer prognosis.
Larsen
Erling Peter
EP
Arhus Universitetshospital, Gynaekologisk Obstetrisk Afdeling, Denmark.
Blaakaer
Jan
J
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D011379:Prognosis; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents